Evidence map›Paper›PMID 38243980›Full record

ReviewCurrent medicinal chemistry2024

How Important is the Metal-free Catalytic Knoevenagel Reaction in Medicinal Chemistry? An Updated Review.

Suzaimi Johari, Mohd Rafie Johan, Nader Ghaffari Khaligh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Larvicidal potential of Knoevenagel adducts againstFuture medicinal chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suzaimi JohariNanotechnology and Catalysis Research Center, Institute for Advanced Studies (IAS), University of Malaya, 50603 Kuala Lumpur, Malaysia.
Mohd Rafie JohanNanotechnology and Catalysis Research Center, Institute for Advanced Studies (IAS), University of Malaya, 50603 Kuala Lumpur, Malaysia.
Nader Ghaffari KhalighNanotechnology and Catalysis Research Center, Institute for Advanced Studies (IAS), University of Malaya, 50603 Kuala Lumpur, Malaysia.

Funding

Ministry of Higher Education, Malaysia IIRG004A-2022FNWNippon Sheet Glass Foundation for Materials Science and Engineering IF008-2023
6 · The paper itself

Abstract

The Knoevenagel condensation is a powerful and primary step for the development of carbon-carbon bond transformations. These condensations offer versatile products/ intermediates for diverse uses in polymers, cosmetics, chemical industries, and medicinal chemistry. Various homogenous and heterogenous catalysts have been found to promote the Knoevenagel condensation reaction, both environmentally and economically. Due to their attractive use in the production of pharmaceutical drugs, they are proven to be the main force that drives the synthesis involving numerous multi-component and multistep reactions. The present study, therefore, aims to summarise reported Knoevenagel condensation reactions using metal-free catalysts resulting in pharmaceutically useful compounds with anti-cancer, anti-tumor, anti-oxidant, anti-malarial, anti-diabetic, and anti- bacterial activities. By considering factors like their structure-activity relationships (SARs), the reaction conditions, and the steps involved, as well as the advantages and limitations of the particular approach, we also provide a general framework and direction in order to achieve superior characteristics of the catalyst.

Indexed as

Chemistry, PharmaceuticalAnti-Bacterial AgentsAntimalarialsAntineoplastic AgentsCatalysisHumansStructure-Activity RelationshipAnti-Bacterial AgentsAntimalarialsAntineoplastic Agentsantibacterialanticancerantidiabetic.antioxidantantivirusKnoevenagel condensation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.